Birdwatch Note Rating
2023-11-24 22:07:58 UTC - HELPFUL
Rated by Participant: 49DAAD9E8411D52A4D322EE19F2A1ED4318B641EE0672C493FC1EAA09AD03FF4
Participant Details
Original Note:
Claim is false. In the trial the effectiveness of the vaccine for severe RSV in babies was 81.8%. The clinical trial efficacy & safety data is publicly available. The available data are insufficient to establish a causal relationship between preterm birth & the vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants https://www.nejm.org/doi/10.1056/NEJMoa2216480 https://www.fda.gov/media/169361/download
All Note Details